An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations-Reference-Cited by-同舟云学术

An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations

Published:2018-04-04 Issue:4 Volume:13 Page:e0194830
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Rajendran Madhusudan,Sun Weina,Comella Phillip,Nachbagauer Raffael,Wohlbold Teddy John,Amanat Fatima,Kirkpatrick Ericka,Palese Peter,Krammer Florian^ORCID

Funder

National Institute of Allergy and Infectious Diseases

Biomedical Advanced Research and Development Authority

GlaxoSmithKline

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference47 articles.

1. A single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen. Proposals for an assay method for the haemagglutinin content of influenza vaccines;G Schild;Bull World Health Organ,1975

2. An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines;JM Wood;J Biol Stand,1977

3. Single-radial-immunodiffusion as an in vitro potency assay for human inactivated viral vaccines;MS Williams;Vet Microbiol,1993

4. THE QUANTITATIVE DETERMINATION OF INFLUENZA VIRUS AND ANTIBODIES BY MEANS OF RED CELL AGGLUTINATION;GK Hirst;J Exp Med,1942

5. Assaying the Potency of Influenza Vaccines;PD Minor;Vaccines (Basel),2015

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in mice;Science Advances;2023-09-15

2. Assessing the stability-indicating properties of alternative potency assays for inactivated influenza vaccine;Vaccine;2023-07

3. Bioprocess development for universal influenza vaccines based on inactivated split chimeric and mosaic hemagglutinin viruses;Frontiers in Bioengineering and Biotechnology;2023-06-05

4. Immunity to Seasonal Coronavirus Spike Proteins Does Not Protect from SARS-CoV-2 Challenge in a Mouse Model but Has No Detrimental Effect on Protection Mediated by COVID-19 mRNA Vaccination;Journal of Virology;2023-03-30

5. Immunity to seasonal coronavirus spike proteins does not protect from SARS-CoV-2 challenge in a mouse model but has no detrimental effect on protection mediated by COVID-19 mRNA vaccination;2022-10-26